Opdivo (nivolumab)

pCPA File Number: 21043
Negotiation Status:
Concluded with an LOI
Indication(s):
Classic Hodgkin's Lymphoma
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
PC0120-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: